Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A pilot study of zoledronic acid as adjuvant therapy to standard anti-vascular endothelial growth factor (anti-VEGF) treatment for neovascular age-related macular degeneration (AMD).
Epistemonikos ID: 582ec75a1ca852e209d1b07b7c32225d05f2c0ae
First added on: May 07, 2024